Spero Therapeutics, Inc(NASDAQ:SPRO) 
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. Its product candidates include tebipenem pivoxil hydrobromide (HB...
Website: http://sperotherapeutics.com
Founded: 2013
Full Time Employees: 57
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.60
H 0.63
L 0.56
C 0.58
V 286,902
10EMA 0.58
20EMA 0.58
60EMA 0.58
120EMA 0.58
250EMA 0.58